Alpine Immune Sciences Inc
ALPN
ALPN was delisted on the 17th of May, 2024.
26 hedge funds and large institutions have $21.1M invested in Alpine Immune Sciences Inc in 2017 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 10 reducing their positions, and 9 closing their positions.
7% less funds holding
Funds holding: 28 → 26 (-2)
13% less capital invested
Capital invested by funds: $24.2M → $21.1M (-$3.09M)
22% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 9
60% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$1.87M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
+$202K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$71.6K |
| 4 |
Morgan Stanley
New York
|
+$45.5K |
| 5 |
Renaissance Technologies
New York
|
+$35K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$429K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$219K |
| 3 |
Millennium Management
New York
|
-$177K |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$169K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$96.3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $2K | +$2.88K | +300 | New |
|
|
PAM
27
Panagora Asset Management
Boston,
Massachusetts
| – | -$429K | -36,762 | Closed |
|
|
BCM
28
Bridgeway Capital Management
Houston,
Texas
| – | -$219K | -18,750 | Closed |
|
|
29
Millennium Management
New York
| – | -$177K | -15,134 | Closed |
|
|
30
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
| – | -$169K | -14,450 | Closed |
|
|
FO
31
FT Options
Chicago,
Illinois
| – | -$63K | -5,361 | Closed |
|
|
SKK
32
Shepherd Kaplan Krochuk
Boston,
Massachusetts
| – | -$44K | -3,750 | Closed |
|
|
TDC
33
Thompson Davis & Co
Richmond,
Virginia
| – | -$3K | -250 | Closed |
|
|
MA
34
MUFG Americas
New York
| – | -$1K | -77 | Closed |
|
ALPN Hedge Fund Activity: Q2 2017 in Review
26 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Alpine Immune Sciences Inc (ALPN) for Q2 2017, worth a combined $21.1M — down 13% from $24.2M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of ALPN and 7 opened new positions — a net loss of 2 holders — while 10 trimmed existing stakes and 4 added.
The largest buyer was BVF Inc, adding an estimated $1.87M. The largest seller was Panagora Asset Management, exiting entirely with an estimated $429K sold.
- 26 institutional investors held Alpine Immune Sciences Inc (ALPN) as of Q2 2017, down from 28 in Q1 2017.
- Funds reported $21.1M of Alpine Immune Sciences Inc stock for Q2 2017, down 13% quarter-over-quarter.
- 7 funds opened new Alpine Immune Sciences Inc positions in Q2 2017 and 9 closed out, a net change of -2 holders.
- The largest Alpine Immune Sciences Inc buyer in Q2 2017 was BVF Inc, an estimated $1.87M added.
- The largest Alpine Immune Sciences Inc seller in Q2 2017 was Panagora Asset Management, an estimated $429K sold.
Based on aggregated 13F filings for Q2 2017.